India willing to collaborate with East Asian partners in the production of generic drugs and medical technologies used for treatment of COVID-19 patients, as also in the area of vaccines production: Anupriya Patel
India looks forward to an early outcome on the TRIPS Waiver proposal for vaccines, therapeutics and diagnostics: Anupriya Patel
Global and equitable vaccine roll-out is a prerequisite for the strong and sustained global recovery
Smt. Patel attended 9th EAS-EMM (East Asia Summit-Economic Ministers’ Meeting) via webinar
****